Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe acute respiratory syndrome‐coronavirus‐2 spike (S) protein based vaccine candidates: State of the art and future prospects
Arash Arashkia, Somayeh Jalilvand, Nasir Mohajel, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 3
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Evaluation of Side Effects Associated with COVID-19 Vaccines in Saudi Arabia
Abdulaziz Alhazmi, Edrous Alamer, Dalia Daws, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 674-674
Open Access | Times Cited: 155
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19
Mohsen Heidary, Vahab Hassan Kaviar, Maryam Shirani, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 131
Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle
Uday Kumar Sukumar, Rayhaneh Afjei, Katherine W. Ferrara, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17582-17601
Open Access | Times Cited: 70
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
Vivek P. Chavda, Gargi Jogi, Srusti Dave, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 507-507
Open Access | Times Cited: 30
Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic Review
Yu-Kuei Lee, Yi-Hsun Huang
Vaccines (2021) Vol. 9, Iss. 12, pp. 1404-1404
Open Access | Times Cited: 44
The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options
Arezoo Beig Parikhani, Masoume Bazaz, Hadi Bamehr, et al.
Current Microbiology (2021) Vol. 78, Iss. 4, pp. 1099-1114
Open Access | Times Cited: 43
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination
Anna Francis, Kariem Elhadd, Valentina Camera, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 34
COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?
Kenneth Lundström, Debmalya Barh, Bruce D. Uhal, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1020-1020
Open Access | Times Cited: 38
Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity
Sunil J. Wimalawansa
Heliyon (2024) Vol. 10, Iss. 15, pp. e34691-e34691
Open Access | Times Cited: 3
mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
Yingqi Jin, C. Hou, Yonghao Li, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 16
RETRACTED: Safety and immunogenicity of a recombinant receptor‐binding domain‐based protein subunit vaccine (Noora vaccine™) against COVID‐19 in adults: A randomized, double‐blind, placebo‐controlled, Phase 1 trial
Jafar Salimian, Ali Ahmadi, Jafar Amani, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 2
Open Access | Times Cited: 16
COVID-19 Vaccines: Current Conditions and Future Prospects
Tarek Zieneldien, Janice Kim, J. Cao, et al.
Biology (2021) Vol. 10, Iss. 10, pp. 960-960
Open Access | Times Cited: 21
Mining Textual and Imagery Instagram Data during the COVID-19 Pandemic
Dimitrios Amanatidis, Ifigeneia Mylona, Irene Kamenidou, et al.
Applied Sciences (2021) Vol. 11, Iss. 9, pp. 4281-4281
Open Access | Times Cited: 20
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8485-8485
Open Access | Times Cited: 15
Looking to the future: is a universal coronavirus vaccine feasible?
Vipin M. Vashishtha, Puneet Kumar
Expert Review of Vaccines (2021) Vol. 21, Iss. 3, pp. 277-280
Open Access | Times Cited: 17
A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination
Zhidong Hu, Jianping Chen, Jinchuan Xu, et al.
Virology (2021) Vol. 566, pp. 56-59
Open Access | Times Cited: 16
Indirect Dispersion of SARS-CoV-2 Live-Attenuated Vaccine and Its Contribution to Herd Immunity
Ursino Pacheco-García, Jeanet Serafín‐López
Vaccines (2023) Vol. 11, Iss. 3, pp. 655-655
Open Access | Times Cited: 6
SARS-CoV-2 sublingual vaccine with RBD antigen and poly(I:C) adjuvant: Preclinical study in cynomolgus macaques
Tetsuro Yamamoto, Masanori Tanji, Fusako Mitsunaga, et al.
Biology Methods and Protocols (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 5
Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach
Patil Pranita Uttamrao, Chakkarai Sathyaseelan, L. Ponoop Prasad Patro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 13
Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development
Niel A. Karrow, Umesh K. Shandilya, Steven Pelech, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1351-1351
Open Access | Times Cited: 13
Global, regional, and national COVID-19 vaccination rate in 237 countries and territories, March 2022: a systematic analysis for World Health Organization COVID-19 Dashboard, Release 2
Rosie Kwon, Masoud Rahmati
Life Cycle (2022) Vol. 2
Open Access | Times Cited: 9
Next Generation RNA/Protein‐Carrying Vector With Pleiotropic Activity
Tetsuya Nosaka, Junpei Ohtsuka, Tomomi Ohtsuka, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 6
Open Access | Times Cited: 1
Searching and designing potential inhibitors for SARS-CoV-2 Mpro from natural sources using atomistic and deep-learning calculations
Nguyễn Minh Tâm, Duc-Hung Pham, Đinh Minh Hiệp, et al.
RSC Advances (2021) Vol. 11, Iss. 61, pp. 38495-38504
Open Access | Times Cited: 12
Side Effects of Mixing Vaccines against COVID-19 Infection among Saudi Population
Mohammed Merae Alshahrani, Abdulaziz Alqahtani
Vaccines (2022) Vol. 10, Iss. 4, pp. 519-519
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top